|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00004361 |
|
Date of registration:
|
18/10/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
July 1995 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00004361 |
|
Study type:
|
Observational |
|
Study design:
|
Primary Purpose: Screening
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Craig B. Langman |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ann & Robert H Lurie Children's Hospital of Chicago |
| | |
|
Key inclusion & exclusion criteria
|
- Diagnostically shown repaired or palliated conotruncal cardiac defects, including
tetralogy of Fallot with pulmonary stenosis or pulmonary atresia, truncus arteriosus,
or interrupted aortic arch type B
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypoparathyroidism
|
|
Conotruncal Cardiac Defects
|
|
Pulmonary Valve Stenosis
|
|
Tetralogy of Fallot
|
|
Heart Defects, Congenital
|
|
Pulmonary Atresia
|
|
Intervention(s)
|
|
Drug: calcium gluconate
|
|
Drug: sodium citrate
|
|
Secondary ID(s)
|
|
199/11936
|
|
NU-553
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|